老年乳腺癌患者芳香化酶抑制剂相关关节痛现状及其影响因素研究
CSTR:
作者:
作者单位:

(南方医科大学第十附属医院·东莞市人民医院乳腺科,广东 东莞 523000)

作者简介:

通讯作者:

中图分类号:

基金项目:

广东省基础与应用基础研究基金(2021A1515010156);东莞市社会发展科技项目(20221800906302)


Prevalence and influencing factors of aromatase inhibitor-induced arthralgia in elderly patients with breast cancer
Author:
Affiliation:

(Department of Galactophore, Tenth Affiliated Hospital of Southern Medical University, Dongguan People′s Hospital, Dongguan 523000, Guangdong Province, China)

Fund Project:

This work was supported by Basic and Applied Basic Research Foundation of Guangdong Province(2021A1515010156)and Dongguan Social Development Science and TechnologyProject(20221800906302).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨老年乳腺癌患者芳香化酶抑制剂(AIs)相关关节痛(AIA)现状,并分析其影响因素。方法 选取南方医科大学第十附属医院2024年6月至2025年1月收治的150例接受AIs治疗的老年乳腺癌患者为研究对象。根据患者是否出现AIA,将其分为AIA组及非AIA组。根据AIA患者数字评定量表(NRS)评分,将其分为轻度疼痛组(NRS评分1~3分)及中度疼痛组(NRS评分4~6分)。收集患者AIA发病时间、关节疼痛部位分布及疼痛强度等资料。采用SPSS 27.0统计软件进行数据分析。根据数据类型,组间比较分别采用t检验或χ2检验。采用二元logistic回归分析老年乳腺癌AIs治疗者AIA发生的影响因素。结果 150例老年乳腺癌患者AIs服药时间均>1个月,出现AIA者72例,AIA发生率为48.00%。72例AIA患者中,服药第1个月及第2个月内出现AIA者占比分别为27.78%(20/72)及43.06%(31/72),服药3个月以后出现AIA者占比仅为6.94%(5/72);疼痛部位主要集中于手和(或)手腕以及膝关节;87.50%(63/72)的患者NRS评分为1~3分。二元logistic回归分析显示,BMI≥24.0 kg/m2(OR=1.514,95%CI 1.068~2.147)、紫杉类化疗(OR=2.130,95%CI 1.111~4.083)是AIA发生的危险因素,补充碳酸钙D3(OR=0.415,95%CI 0.244~0.708)是其保护因素(P<0.05)。AIA轻度疼痛者63例(87.50%)、中度疼痛者9例(12.50%)。AIA中度疼痛组年龄>79岁、BMI≥24.0 kg/m2、从不运动及焦虑者占比高于轻度疼痛组,补充碳酸钙D3者占比低于轻度疼痛组,差异均有统计学意义(均P<0.05)。结论 老年乳腺癌AIs治疗者AIA发生率高,BMI≥24.0 kg/m2、紫杉类化疗是AIA发生的危险因素,补充碳酸钙D3是其保护因素。同时,年龄、BMI、运动频率、焦虑以及补充碳酸钙D3是可能影响AIA患者疼痛程度的相关因素。

    Abstract:

    Objective To explore the status quo of aromatase inhibitor (AIs)-induced arthralgia (AIA) in elderly patients with breast cancer and to analyze its influencing factors. Methods A total of 150 elderly breast cancer patients who received AIs in the Tenth Affiliated Hospital of Southern Medical University were selected as the study subjects. According to occurrence of AIA, the patients were divided into an AIA group and a non-AIA group. Based on the numerical rating scale (NRS) scores of AIA patients, they were further divided into a mild pain group (NRS score of 1-3 points) and a moderate pain group (NRS score of 4-6 points). The data on the time of AIA onset, distribution of pain joints, and pain intensity were collected. SPSS 27.0 was used for data processing. According to the data type, t test or Chi-square test was used for comparison between groups. Binary logistic regression was used to analyze the influencing factors for AIA in elderly breast cancer patients treated with AIs. Results All the 150 elderly patients with breast cancer took AIs for more than one month, and 72 patients developed AIA with an incidence of 48.00%. Among 72 AIA patients with, the proportions of those developing AIA within the 1st month and 2nd month of medication were 27.78% (20/72) and 43.06% (31/72), and only 6.94% (5/72) of the patients developed AIA after 3 months of medication. The pain were mainly localized in the hand/wrist and knees, and 87.50% (63/72) of patients had NRS score of 1-3 points. Binary logistic regression analysis suggested that BMI ≥ 24.0 kg/m2 (OR=1.514,95%CI 1.068-2.147) and taxane chemotherapy (OR=2.130,95%CI 1.111-4.083) were risk factors for AIA occurrence, and calcium carbonate D3 supplementation (OR=0.415,95%CI 0.244-0.708) was a protective factor. Among AIA patients, 63 (87.50%) experienced mild pain and 9 (12.50%) moderate pain. The proportions of patients with age > 79 years, BMI ≥ 24.0 kg/m2, never exercising, and anxiety were higher in the moderate pain group than those in the mild pain group, while the proportion of patients receiving calcium carbonate D3 supplementation was lower in the moderate pain group than that in mild pain group; all differences were statistically significan (all P<0.05). Conclusion The incidence of AIA is high in elderly breast cancer patients treated with AIs. BMI ≥ 24.0 kg/m2 and taxane chemotherapy are risk factors for AIA, and calcium carbonate D3 supplementation is a protective factor. Additionally, age, BMI, exercise frequency, anxiety, and calcium carbonate D3 supplementation are factors affecting the pain intensity in patients with AIA.

    参考文献
    相似文献
    引证文献
引用本文

袁敏如,杜笑兰,李丽霞.老年乳腺癌患者芳香化酶抑制剂相关关节痛现状及其影响因素研究[J].中华老年多器官疾病杂志,2026,25(5):372-377
DOI:10.11915/j. issn.1671-5403.2026.05.076

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-05-27
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-05-26
  • 出版日期:
文章二维码